After delivering a billion doses to fight the bacterial disease, Pfizer offers 3 lessons Kampala, Uganda | AGENCIES | Imagine an infection that causes your eyelids to turn inward, so that your lashes intended to protect your eyes scrape against the sensitive outer surface of your eye every time you blink. …
Read More »
New medicines and vaccines to be availed on a not-for-profit basis Kampala, Uganda | AGENCIES | Drug manufacturer Pfizer Inc. has announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccines for which it has global rights …
Read More »
Pfizer and BioNTech to test a candidate | THE INDEPENDENT | Pfizer and BioNTech announced a new clinical trial for universal COVID-19 vaccine candidates.They say the candidates will include T-cell enhancing shots and pan-coronavirus shots that “protect against the broader family of viruses and its mutations.” A key challenge for …
Read More »
Jerusalem, Israel | Xinhua | A new Israeli-led study has found that the fourth dose of COVID-19 vaccine is effective for protecting people who are 60 and older, Israel’s largest healthcare organization Clalit said on Thursday. The study found that a fourth dose can reduce the possibilities of symptomatic infection, hospitalization, …
Read More »
New York, U.S. | Xinhua | U.S. pharmaceutical company Pfizer Inc. on Tuesday presented weaker-than-expected operating guidance for 2022 leading to material loss of its stock price. Pfizer expects to realize 98 billion to 102 billion U.S. dollars of revenues in 2022 and the mid-point of the guidance range represents a …
Read More »
Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer have started clinical trials of an Omicron-based COVID-19 vaccine candidate in healthy adults 18 through 55 years of age, the companies said on Tuesday. The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according …
Read More »
New York, U.S. | Xinhua | Omicron was officially announced on Tuesday as the absolutely dominant variant of COVID-19 in the United States, as the country is entering the third year of the pandemic, with more curing pills ordered from Pfizer while the federal government’s policies criticized as murky. OMICRON DOMINANCE …
Read More »
Washington, U.S. | Xinhua | The U.S. Food and Drug Administration on Wednesday authorized Pfizer’s oral antiviral tablets for the treatment of mild-to-moderate COVID-19, the first pill approved for COVID-19 treatment in the country. The pill, called Paxlovid, is authorized for use in adults and pediatric patients 12 years of age …
Read More »
The Hague, Netherlands | Xinhua | The European Medicines Agency (EMA) on Thursday issued advice on the emergency use of Pfizer’s COVID-19 pill called Paxlovid. The European Union (EU) drug regulator said the medicine, which is not yet authorized in the EU, can be used to treat adults with COVID-19 who …
Read More »
New York, U.S. | Xinhua | U.S. pharmaceutical giant Pfizer Inc. Tuesday said final results show that its novel COVID-19 oral antiviral tablets could reduce risk of hospitalization or death by close to 90 percent for high-risk patients. The results, based on an analysis of over 2,000 patients in a phase …
Read More »
The Independent Uganda: You get the Truth we Pay the Price